Drug Trial Radar · NCT06413433
Elucidating TAAR-1, Dopamine, and Norepinephrine in Binge Eating Disorder Using Solriamfetol
Last checked: Nov 20, 2026Latest source record: Jul 28, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
450
Planned (sponsor's estimate)
Start
Apr 26, 2024
Primary completion
Dec 2026
Study completion Dec 2026
Sponsor
- Lead sponsor
- Axsome Therapeutics, Inc.Industry
- Sponsor type
- Industry
- First posted
- May 14, 2024
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 55 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
ENGAGE (Elucidating TAAR-1, Dopamine, and Norepinephrine in Binge Eating Disorder Using Solriamfetol) is a Phase 3, randomized, double-blind, placebo-controlled, multicenter trial to assess the efficacy and safety of solriamfetol for the treatment of binge eating disorder (BED) in adults.
Conditions
- Binge-Eating Disorder
Interventions
Solriamfetol 150 mgDrug
Solriamfetol tablets, taken once daily
Solriamfetol 300 mgDrug
Solriamfetol tablets, taken once daily
PlaceboDrug
Placebo tablets, taken once daily
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change from Baseline to Week 12 in number of binge eating episodesTime frame: 12 weeks
Locations
45 sites in 1 country. Site status is shown where the registry gives one.
Clinical Research Site
Encino, California · Recruiting
Clinical Research Site
Garden Grove, California · Recruiting
Clinical Research Site
Long Beach, California · Recruiting
Clinical Research Site
Mission Viejo, California · Recruiting
Clinical Research Site
San Diego, California · Terminated
Clinical Research Site
Santa Ana, California · Recruiting
Clinical Research Site
Walnut Creek, California · Recruiting
Clinical Research Site
West Covina, California · Recruiting
Clinical Research Site
Colorado Springs, Colorado · Recruiting
Clinical Research Site
Cromwell, Connecticut · Recruiting
Clinical Research Site
Clermont, Florida · Terminated
Clinical Research Site
Fort Myers, Florida · Recruiting
Clinical Research Site
Jacksonville, Florida · Recruiting
Clinical Research Site
Lauderhill, Florida · Recruiting
Clinical Research Site
Miami, Florida · Recruiting
Clinical Research Site
Miami, Florida · Recruiting
Clinical Research Site
Miami Lakes, Florida · Recruiting
Clinical Research Site
Miami Lakes, Florida · Terminated
Clinical Research Site
Orlando, Florida · Recruiting
Clinical Research Site
Orlando, Florida · Terminated
Clinical Research Site
Marietta, Georgia · Recruiting
Clinical Research Site
Overland Park, Kansas · Recruiting
Clinical Research Site
Boston, Massachusetts · Recruiting
Clinical Research Site
Methuen, Massachusetts · Terminated
Clinical Research Site
Saint Charles, Missouri · Recruiting
Clinical Research Site
Cherry Hill, New Jersey · Recruiting
Clinical Research Site
Princeton, New Jersey · Recruiting
Clinical Research Site
Mount Kisco, New York · Recruiting
Clinical Research Site
New York, New York · Recruiting
Clinical Research Site
Raleigh, North Carolina · Recruiting
Clinical Research Site
Cincinnati, Ohio · Recruiting
Clinical Research Site
Mason, Ohio · Recruiting
Clinical Research Site
Middleburg Heights, Ohio · Recruiting
Clinical Research Site
North Canton, Ohio · Terminated
Clinical Research Site
Portland, Oregon · Recruiting
Clinical Research Site
Allentown, Pennsylvania · Recruiting
Clinical Research Site
Media, Pennsylvania · Recruiting
Clinical Research Site
Greenville, South Carolina · Recruiting
Clinical Research Site
North Charleston, South Carolina · Recruiting
Clinical Research Site
Memphis, Tennessee · Recruiting
Showing 40 of 45 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.